JPS54140596A - - Google Patents

Info

Publication number
JPS54140596A
JPS54140596A JP4677279A JP4677279A JPS54140596A JP S54140596 A JPS54140596 A JP S54140596A JP 4677279 A JP4677279 A JP 4677279A JP 4677279 A JP4677279 A JP 4677279A JP S54140596 A JPS54140596 A JP S54140596A
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP4677279A
Other languages
Japanese (ja)
Other versions
JPS6318139B2 (cg-RX-API-DMAC7.html
Inventor
Teimupuru Ruuperuto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Max-Planck-Gesellschaft zur Förderung der Wissenschaften eV
Original Assignee
Max-Planck-Gesellschaft zur Förderung der Wissenschaften eV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max-Planck-Gesellschaft zur Förderung der Wissenschaften eV filed Critical Max-Planck-Gesellschaft zur Förderung der Wissenschaften eV
Publication of JPS54140596A publication Critical patent/JPS54140596A/ja
Publication of JPS6318139B2 publication Critical patent/JPS6318139B2/ja
Expired legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/804—Radioisotope, e.g. radioimmunoassay
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/824—Immunological separation techniques
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/842—Skin; hair; nails; sebaceous glands; cerumen

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Enzymes And Modification Thereof (AREA)
JP54046772A 1978-04-18 1979-04-18 Expired JPS6318139B2 (cg-RX-API-DMAC7.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19782816841 DE2816841A1 (de) 1978-04-18 1978-04-18 Radioimmunologische bestimmung von prokollagen (typ iii) und prokollagen- peptid (typ iii)

Publications (2)

Publication Number Publication Date
JPS54140596A true JPS54140596A (cg-RX-API-DMAC7.html) 1979-10-31
JPS6318139B2 JPS6318139B2 (cg-RX-API-DMAC7.html) 1988-04-16

Family

ID=6037323

Family Applications (3)

Application Number Title Priority Date Filing Date
JP54046772A Expired JPS6318139B2 (cg-RX-API-DMAC7.html) 1978-04-18 1979-04-18
JP62174036A Granted JPS63126496A (ja) 1978-04-18 1987-07-14 プロコラ−ゲン・ペプチド(3型)特異抗血清の製法
JP62174037A Granted JPS63109796A (ja) 1978-04-18 1987-07-14 高純度プロコラ−ゲン・ペプチド(3型)の製法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP62174036A Granted JPS63126496A (ja) 1978-04-18 1987-07-14 プロコラ−ゲン・ペプチド(3型)特異抗血清の製法
JP62174037A Granted JPS63109796A (ja) 1978-04-18 1987-07-14 高純度プロコラ−ゲン・ペプチド(3型)の製法

Country Status (5)

Country Link
US (1) US4312853A (cg-RX-API-DMAC7.html)
EP (1) EP0004940B1 (cg-RX-API-DMAC7.html)
JP (3) JPS6318139B2 (cg-RX-API-DMAC7.html)
AT (1) AT362529B (cg-RX-API-DMAC7.html)
DE (2) DE2816841A1 (cg-RX-API-DMAC7.html)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59216826A (ja) * 1983-05-24 1984-12-06 Mitsubishi Chem Ind Ltd 抗血清
JPS63238558A (ja) * 1987-03-24 1988-10-04 テクニオン リサ−チ アンド デイベロプメント フアウンデ−シヨン リミテイド 妊娠障害の測定方法

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2816841A1 (de) * 1978-04-18 1979-10-31 Max Planck Gesellschaft Radioimmunologische bestimmung von prokollagen (typ iii) und prokollagen- peptid (typ iii)
DE3209149A1 (de) * 1982-03-13 1983-10-06 Hoechst Ag Verfahren zur gemeinsamen immunologischen bestimmung von prokollagen-peptid (typ iii) und prokollagen-peptid col 1 (typ iii) und verfahren zur herstellung von anti-prokollagen-peptid col 1 (typ iii)-serum
US4628027A (en) * 1982-05-19 1986-12-09 Molecular Engineering Associates, Ltd. Vitro diagnostic methods using monoclonal antibodies against connective tissue proteins
CA1251729A (en) * 1982-05-19 1989-03-28 Steffen Gay In vitro diagnostic methods using monoclonal antibodies against connective tissue proteins
DE3331627A1 (de) * 1983-09-01 1985-03-21 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Verfahren zur immunologischen bestimmung fuer proteine in koerperfluessigkeiten, unter verwendung monovalenter antikoerperfragmente
SE8304836D0 (sv) * 1983-09-09 1983-09-09 Pharmacia Ab Sett att bestemma forendringar i ledbrosk
US5316914A (en) * 1986-09-04 1994-05-31 Fuji Yakuhin Kogyo Kabushiki Kaisha Method for determining human collagen peptides by way of enzyme immunoassay
DE3714634A1 (de) * 1987-05-02 1988-11-17 Hoechst Ag Verfahren zur selektiven immunologischen bestimmung von intaktem prokollagen peptid (typ iii) und prokollagen (typ iii) in koerperfluessigkeiten und mittel zu dessen durchfuehrung
US5679583A (en) * 1987-05-02 1997-10-21 Hoechst Aktiengesellschaft Monoclonal antibodies for the selective immunological determination of intact procollagen peptide (type III) and procollagen (type III) in body fluids
GB2208865B (en) * 1987-08-19 1991-12-11 Farmos Group Ltd Purified propeptide of procollagen type iii, antibody to the propeptide and assay method using the antibody.
US4973666A (en) * 1987-11-06 1990-11-27 Washington Research Foundation Peptide fragments containing HP and LP cross-links
US6010862A (en) * 1987-11-06 2000-01-04 Washington Research Foundation Methods of detecting collagen type III degradation in vivo
US5300434A (en) * 1987-11-06 1994-04-05 Washington Research Foundation Hybridoma cell line producing an antibody to type-I collagen amino-terminal telopeptide
US5320970A (en) * 1987-11-06 1994-06-14 Washington Research Foundation Detection of collagen degradation in vivo
US5962639A (en) * 1987-11-06 1999-10-05 Washington Research Foundation Synthetic peptides corresponding to telopeptide sequences of cross-linked type I collagen metabolites
US6027903A (en) * 1987-11-06 2000-02-22 Washington Research Foundation Kit for detecting analyte indicative of type I collagen resorption in vivo
US5702909A (en) * 1987-11-06 1997-12-30 Washington Research Foundation Methods of detecting collagen type II degradation in vivo
US6153732A (en) * 1987-11-06 2000-11-28 Washington Research Foundation Kit for detecting analyte indicative of type II collagen resorption in vivo
US5217903A (en) * 1990-05-15 1993-06-08 Trustees Of Boston University Measuring connective tissue breakdown products in body fluids
US5541295A (en) * 1993-02-12 1996-07-30 The Board Of Governors For Higher Education State Of Rhode Island And Providence Plantations Detection of type II collagen and its peptides
US6110689A (en) * 1994-01-21 2000-08-29 Osteometer A/S Method of assaying collagen fragments in body fluids, a test kit and means for carrying out the method and use of the method to diagnose the presence of disorders associated with the metabolism of collagen
WO1996012193A1 (en) 1994-10-17 1996-04-25 Osteometer Bio Tech A/S Estimation of the fragmentation pattern of collagen in body fluids and the diagnosis of disorders associated with the metabolism of collagen
GB9506050D0 (en) 1995-03-24 1995-05-10 Osteometer A S Assaying collagen fragments in body fluids
US6107047A (en) * 1996-03-21 2000-08-22 Osteometer Biotech A/S Assaying protein fragments in body fluids
GB9617616D0 (en) 1996-08-22 1996-10-02 Osteometer Biotech As Assaying protein fragments in body fluids
ES2160985T3 (es) 1996-12-09 2001-11-16 Osteometer Biotech As Ensayos de tipo sandwich para fragmentos de colageno.
US6117646A (en) * 1997-09-22 2000-09-12 Osteometer Biotech A/S Assaying protein fragments in body fluids
EP1086135B1 (en) 1998-05-28 2004-02-25 Bayer HealthCare AG "monoclonal anitbody and assay for detecting n-terminal procollagen (iii) propeptide (piiinp)"
US6602980B1 (en) 1998-06-19 2003-08-05 Washington Research Foundation Collagen type III synthetic peptides for collagen resorption assays
US6916903B2 (en) * 1998-06-19 2005-07-12 Washington Research Foundation Collagen type III synthetic peptides for collagen resorption assays
AU2000278128B2 (en) * 2000-08-21 2006-07-20 Assistance Publique - Hopitaux De Paris Diagnosis method of fibrotic disease using biochemical markers
US6631330B1 (en) * 2000-08-21 2003-10-07 Assistance Publique-Hopitaux De Paris (Ap-Hp) Diagnosis method of inflammatory, fibrotic or cancerous disease using biochemical markers
RU2236686C1 (ru) * 2003-01-21 2004-09-20 Хохлов Платон Платонович Способ определения концентрации аутоантител, специфичных к f-протеину печени человека, в биологических жидкостях человека, содержащих специфичные аутоантитела
WO2021001937A1 (ja) 2019-07-02 2021-01-07 コニカミノルタ株式会社 熱硬化性インクジェットインク
CN114651050B (zh) 2019-11-08 2022-11-29 柯尼卡美能达株式会社 热固化性喷墨墨及打印方法
CN116171292B (zh) 2020-09-18 2026-03-17 柯尼卡美能达株式会社 固化性组合物、阻焊剂用墨及印刷电路基板
JP7600617B2 (ja) 2020-10-26 2024-12-17 コニカミノルタ株式会社 インクジェット捺染インクおよび画像形成方法
EP4201681B1 (en) 2020-11-12 2025-12-10 Konica Minolta, Inc. Inkjet recording method and inkjet recording device
JP7651971B2 (ja) 2021-06-17 2025-03-27 コニカミノルタ株式会社 捺染用インク
JP7753937B2 (ja) 2022-03-17 2025-10-15 コニカミノルタ株式会社 インクジェットインク組成物、記録物、インクジェット記録方法及びインクジェット記録システム
WO2025004730A1 (ja) 2023-06-30 2025-01-02 コニカミノルタ株式会社 塗膜形成方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE343949B (cg-RX-API-DMAC7.html) * 1966-06-02 1972-03-20 Pharmacia Ab
DE2816841A1 (de) * 1978-04-18 1979-10-31 Max Planck Gesellschaft Radioimmunologische bestimmung von prokollagen (typ iii) und prokollagen- peptid (typ iii)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59216826A (ja) * 1983-05-24 1984-12-06 Mitsubishi Chem Ind Ltd 抗血清
JPS63238558A (ja) * 1987-03-24 1988-10-04 テクニオン リサ−チ アンド デイベロプメント フアウンデ−シヨン リミテイド 妊娠障害の測定方法

Also Published As

Publication number Publication date
JPH0144319B2 (cg-RX-API-DMAC7.html) 1989-09-27
AT362529B (de) 1981-05-25
EP0004940A1 (de) 1979-10-31
JPS63126496A (ja) 1988-05-30
JPS63109796A (ja) 1988-05-14
JPH02672B2 (cg-RX-API-DMAC7.html) 1990-01-09
DE2961118D1 (en) 1981-12-10
ATA263679A (de) 1980-10-15
EP0004940B1 (de) 1981-09-30
JPS6318139B2 (cg-RX-API-DMAC7.html) 1988-04-16
US4312853A (en) 1982-01-26
DE2816841A1 (de) 1979-10-31

Similar Documents

Publication Publication Date Title
FR2413932B1 (cg-RX-API-DMAC7.html)
FR2415119B1 (cg-RX-API-DMAC7.html)
FR2415900B1 (cg-RX-API-DMAC7.html)
FR2417057B1 (cg-RX-API-DMAC7.html)
DE2954445A1 (cg-RX-API-DMAC7.html)
FR2416432B1 (cg-RX-API-DMAC7.html)
FR2414327B3 (cg-RX-API-DMAC7.html)
FR2415482B3 (cg-RX-API-DMAC7.html)
AU3892778A (cg-RX-API-DMAC7.html)
AU73950S (cg-RX-API-DMAC7.html)
BG26006A1 (cg-RX-API-DMAC7.html)
BG25956A1 (cg-RX-API-DMAC7.html)
BG26007A1 (cg-RX-API-DMAC7.html)
BG25898A1 (cg-RX-API-DMAC7.html)
BG25917A1 (cg-RX-API-DMAC7.html)
BG25858A1 (cg-RX-API-DMAC7.html)
BG25955A1 (cg-RX-API-DMAC7.html)
BG25921A1 (cg-RX-API-DMAC7.html)
BG26009A1 (cg-RX-API-DMAC7.html)
BG26879A1 (cg-RX-API-DMAC7.html)
BG25842A1 (cg-RX-API-DMAC7.html)
BG26022A1 (cg-RX-API-DMAC7.html)
BG26014A1 (cg-RX-API-DMAC7.html)
BG26579A1 (cg-RX-API-DMAC7.html)
BG25902A1 (cg-RX-API-DMAC7.html)